Cytotoxic pathways activated by multifunctional thiosemicarbazones targeting sigma-2 receptors in breast and lung carcinoma cells

CONCLUSIONS: Our data suggest that FA4 is a promising compound that deserves to be further studied for lung and breast cancer treatment. However, the other multifunctional TSCs also hold promise for the development of therapies towards a personalized medicine approach. Indeed, the presence of the sigma-2 receptor-targeting moiety would lead to a more specific tumor delivery embracing the characteristics of individual tumor types.PMID:37796435 | DOI:10.1007/s43440-023-00531-y

Source: Pharmacological Reports - October 5, 2023 Category: Drugs & Pharmacology Authors: Joanna Kopecka Alessandra Barbanente Daniele Vitone Fabio Arnesano Nicola Margiotta Paola Berchialla Mauro Niso Chiara Riganti Carmen Abate Source Type: research